Obviously, the progress in the field of genetic research helped the clinical trials become cheaper and faster. This strengthened the belief that remedy the disease hard to cure, is rare now too far away. The FDA now has dedicated a special considerations for these types of drugs to treat such diseases; so the companies can expect that ratification would be easier.
đang được dịch, vui lòng đợi..
